,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['bcsm', 'breast', 'destiny-breast04']
standing ovation for results of destiny-breast04. this will change practice for 50% of patients with metastatic breast cancer. this is why we all went into this field. #bcsm #asco22 
Breast & gyn med onc @valleyhospital in NJ. Focus on survivorship and ?????? onc. All opinions my own. Retweets not endorsements. Host of INTERLUDE podcast ??